TREA

79253337 - DUOHEXABODY

Follow

Information

  • Trademark
  • 79253337
  • Serial Number
    79253337
  • Registration Number
    5993053
  • Filing Date
    November 15, 2018
    6 years ago
  • Registration Date
    February 25, 2020
    5 years ago
  • Transaction Date
    April 25, 2025
    5 months ago
  • Status Date
    February 25, 2020
    5 years ago
  • Published for Opposition Date
    December 10, 2019
    5 years ago
  • Location Date
    February 25, 2020
    5 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    CAPSHAW, DANIEL
  • Attorney Docket Number
    38423/64
    Attorney Name
    Max Vern
    Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
4
Mark Identification
DUOHEXABODY
Case File Statements
  • GS0051: Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, bi- and multispecific antibodies as well as antibody fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases
  • PM0001: DUO HEXA BODY
  • GS0011: Chemical, biochemical, biological, and biotechnological preparations, namely, antibodies, bi- and multispecific antibodies as well as antibody fragments, including monovalent antibodies, and derivatives or conjugates of any of these, for in vitro and in vivo scientific and industrial research and development with regard to diseases; Active chemical ingredients for use in the manufacture of pharmaceuticals
  • GS0451: Legal services in the field of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine
  • GS0421: Medical, scientific and biological research, especially research into antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these
Case File Event Statements
  • 3/7/2019 - 6 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/28/2019 - 6 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 3/6/2019 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/6/2019 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/8/2019 - 6 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/12/2019 - 6 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/20/2019 - 6 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/20/2019 - 6 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 4/6/2019 - 6 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 9/5/2019 - 6 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/5/2019 - 6 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/5/2019 - 6 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/13/2019 - 6 years ago
    14 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 9/13/2019 - 6 years ago
    13 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 9/13/2019 - 6 years ago
    15 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 9/19/2019 - 6 years ago
    16 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 10/31/2019 - 5 years ago
    17 - CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED Type: CORR
  • 10/31/2019 - 5 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/5/2019 - 5 years ago
    19 - ASSIGNED TO LIE Type: ALIE
  • 11/20/2019 - 5 years ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/10/2019 - 5 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/10/2019 - 5 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/25/2020 - 5 years ago
    23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/25/2020 - 5 years ago
    24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/22/2020 - 5 years ago
    25 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 6/22/2020 - 5 years ago
    26 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 7/10/2020 - 5 years ago
    27 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 6/5/2024 - a year ago
    33 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 6/5/2024 - a year ago
    31 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 6/5/2024 - a year ago
    32 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/5/2024 - a year ago
    28 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 6/5/2024 - a year ago
    29 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 6/5/2024 - a year ago
    30 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/25/2025 - 7 months ago
    34 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 4/24/2025 - 5 months ago
    35 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP